NEW YORK, March 4 - Celera Genomics, in a move to hasten its metamorphosis as a drug developer, has sold its AgGen animal genomics and genotyping business to MetaMorphix, the companies said on Monday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.